MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors

NCT00350233 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-09-17

No results posted yet for this study

Summary

The objective of this trial is to evaluate the safety and effectiveness of MRgFUS in the treatment of metastatic bone tumors.

Conditions

Interventions

DEVICE

ExAblate 2000

Sponsors & Collaborators

  • InSightec

    lead INDUSTRY

Principal Investigators

  • Christine Chung, M.D. · University of California, San Diego

  • David Gianfelice, M.D. · Toronto General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350233 on ClinicalTrials.gov